---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-008592"
form_type: "8-K"
ticker: "GNPX"
cik: "0001595248"
company_name: "Genprex, Inc."
filed_at: "2024-03-20T23:59:59+00:00"
generated_at: "2026-06-04T11:38:17.419588+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Genprex raises $6.5M in registered direct offering with warrants; existing warrants amended

## Summary
- Gross proceeds $6.5M; net estimated ~$5.8M after placement agent fees and expenses.
- Offers 1,542,112 shares or pre-funded warrants plus 1,542,112 warrants at $4.215 per unit.
- Warrants exercisable at $4.09 per share, expire 5 years from issuance.
- Amends existing warrants for 194,248 shares from $44/$35.40 to $4.09 exercise price; extends expiration to 5 years from closing.
- H.C. Wainwright acts as placement agent; receives 7% cash fee and 92,527 placement agent warrants.

## SEC filing metadata
- accession: 0001437749-24-008592
- form_type: 8-K
- ticker: GNPX
- cik: 0001595248
- company_name: Genprex, Inc.
- filed_at: 2024-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/0001437749-24-008592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/gnpx20240305_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-008592
- JSON: https://secwatch.observer/filing/0001437749-24-008592.json
- Plain text: https://secwatch.observer/filing/0001437749-24-008592.txt

## Key facts
- Material Agreements
  Genprex, Inc. entered into Purchase Agreement with an institutional investor valued at approximately $5.8 million (effective 2024-03-19).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Value: approximately $5.8 million
  - Effective: 2024-03-19
  source text: On March 19, 2024, Genprex, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/0001437749-24-008592-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.